Esophageal Squamous Cell Carcinoma Clinical Trials in Chengdu, Sichuan
5 recruitingChengdu, Sichuan, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Intensive Nutritional Support in Conversion Therapy for Locally Advanced Unresectable ESCC
Esophageal Squamous Cell CarcinomaLocally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Sichuan University118 enrolled1 locationNCT07519486
Recruiting
Phase 2
Low-dose Radiation Combined With Neoadjuvant Immunochemotherapy for Esophageal Squamous Cell Carcinoma
Esophageal Squamous Cell Carcinoma
Sichuan University30 enrolled1 locationNCT06446726
Recruiting
Phase 1
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
Esophageal Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06654297
Recruiting
Phase 2
Low-Dose Involved-Field Radiotherapy Plus Immunochemotherapy for ESCC
ImmunotherapyEsophageal Squamous Cell Carcinoma (ESCC)
Sichuan University41 enrolled1 locationNCT06603402
Recruiting
Phase 1
Neoadjuvant Adebrelimab With Dalpiciclib for Resectable Esophageal Squamous Cell Carcinomas
Esophageal Squamous Cell Carcinoma
West China Hospital6 enrolled1 locationNCT06225921